| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.1 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.025 | 0.8 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.091 | 0.8 |